CADTH conducted a Health Technology Review on remdesivir, an antiviral drug currently being used to treat COVID-19. Presently, remdesivir is not approved in Canada and access to it is limited to clinical trials. Four randomized controlled trials were identified (two completed and two ongoing) in the review; however, due to insufficient published evidence, the potential place in therapy of remdesivir is unknown.
Link to Report
Was this site helpful?
If you couldn’t find what you are looking for, please submit a request.